Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 612
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07676266 A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory … |
C-CAR168 | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | RenJi Hospital | China · The Affiliated Hospital of Qingdao University… | 2026-07 → 2028-10 | Ouvrir |
| NCT04544449 FENtrepid — A Study to Evaluate the Efficacy and Safety of Fenebrutinib… |
Fenebrutinib | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Australia, Austria, Brazil,… | 2020-10-26 → 2027-07-21 | Ouvrir |
| NCT07341828 A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmu… |
C-CAR168 | SEP | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | RenJi Hospital | Non communiqué | 2026-02 → 2029-02 | Ouvrir |
| NCT06249438 CAR-AID — A Study of C-CAR168 in the Treatment of Autoimmune Diseases R… |
C-CAR168 | SEP | Phase 1 | RECRUITING | En attente / non publié | RenJi Hospital | China · Department of Rheumatology, RenJi Hospital, S… | 2024-03-20 → 2040-03 | Ouvrir |
| NCT06595706 Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses … |
Lucid-MS (Lucid-21-302) | SEP | Phase 1 | COMPLETED | En attente / non publié | Huge Biopharma Australia Pty Ltd | Australia · Cmax Clinical Research, Adelaide, Austral… | 2024-09-28 → 2025-01-24 | Ouvrir |
| NCT05821387 Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Fo… |
Lucid-MS (Lucid-21-302) | SEP | Phase 1 | COMPLETED | En attente / non publié | Huge Biopharma Australia Pty Ltd | Canada · Biopharma Services Incorporated, Toronto, Ca… | 2023-03-22 → 2023-07-29 | Ouvrir |
| NCT01702025 Rapid Acclimatization to Hypoxia at Altitude |
Aminophylline | SEP | Phase 1/2 | COMPLETED | En attente / non publié | Thies Schroeder | United States · Colorado State University, Dept. of H… | 2012-06 → 2012-12 | Ouvrir |
| NCT01412827 SPECT-Light — Accuracy of Half of the Usual Radiotracer Dose in SPECT |
1/2 dose of 99mTc OR 201Tl tracers | SEP | Non applicable | COMPLETED | En attente / non publié | Ottawa Heart Institute Research C… | Canada · University of Ottawa Heart Institute, Ottawa… | 2010-04 → 2014-09 | Ouvrir |
| NCT05666219 Reversal of Complete Heart Block With Aminophylline in Inferior Wall My… |
Aminophylline Injection | SEP | Phase 4 | WITHDRAWN | En attente / non publié | National Institute of Cardiovascu… | Non communiqué | 2022-12-19 → 2025-01-17 | Ouvrir |
| NCT01655524 ASSUAGE-MPI — The Impact of the Routine Aminophylline Administration Fo… |
ASSUAGE Protocol | SEP | Phase 4 | WITHDRAWN | En attente / non publié | Rush University Medical Center | United States · Rush University Medical Center, Chica… | 2012-07 → 2014-07 | Ouvrir |
| NCT02983422 Effects of Aminophylline on Renal Function and Urine Volume of AKI Pati… |
Aminophylline | SEP | Phase 1 | UNKNOWN | En attente / non publié | Thies Schroeder | Non communiqué | 2016-12 → 2017-07 | Ouvrir |
| NCT04240821 Theophylline for Treatment of Pseudohypoparathyroidism |
Theophylline ER | SEP | Phase 2 | ENROLLING_BY_INVITATION | En attente / non publié | Jaclyn Tamaroff | United States · Vanderbilt University Medical Center,… | 2020-05-22 → 2026-12-31 | Ouvrir |
| NCT01509248 Population Pharmacokinetics and Metabolomics of Theophylline in Preterm… |
Population Pharmacokinetics and M… | SEP | À vérifier | UNKNOWN | En attente / non publié | Seoul National University Hospital | Non communiqué | 2010-05 | Ouvrir |
| NCT03718403 Effect of Theophylline in Pseudohypoparathyroidism |
Theophylline | SEP | Phase 4 | RECRUITING | En attente / non publié | Massachusetts General Hospital | United States · Massachusetts General Hospital, Bosto… | 2019-11-11 → 2032-04-10 | Ouvrir |
| NCT01684683 The Effect of Theophylline in the Treatment of Bronchiectasis |
Theophylline | SEP | Phase 4 | COMPLETED | En attente / non publié | Massachusetts General Hospital | China · State Key Laboratory of Respiratory Research … | 2012-11 → 2014-09 | Ouvrir |
| NCT01263106 A Study of LY2216684 and Theophylline in Healthy Subjects |
LY2216684 | SEP | Phase 1 | COMPLETED | En attente / non publié | Eli Lilly and Company | United States · For additional information regarding … | 2010-12 → 2011-01 | Ouvrir |
| NCT06868160 Comparison of Different Non-invasive Electrical Stimulation Protocols t… |
Sham tDCS | Parkinson | Non applicable | RECRUITING | En attente / non publié | Universitat Oberta de Catalunya | Italy · San Raffaele Neurotech Hub, Milan, Italy | 2025-10-08 → 2029-01 | Ouvrir |
| NCT07636876 RISM — The Italian Multiple Sclerosis and Related Disorders Register |
RISM — The Italian Multiple Scler… | SEP | À vérifier | ENROLLING_BY_INVITATION | En attente / non publié | Fondazione Italiana Sclerosi Mult… | Italy · Fondazione Italiana Sclerosi Multipla (FISM E… | 2014-09-17 → 2026-07 | Ouvrir |
| NCT05017142 Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) |
Swiss Pediatric Inflammatory Brai… | SEP | À vérifier | RECRUITING | En attente / non publié | University of Bern | Switzerland · Children's Hospital of Eastern Switzerl… | 2020-04-14 → 2071-01-01 | Ouvrir |
| NCT06502015 Biomarkers in Autoimmune Disease of Nervous System |
Biomarkers in Autoimmune Disease … | SEP | À vérifier | RECRUITING | En attente / non publié | Tongji Hospital | China · Tongji Hospital, Tongji Medical College, Huaz… | 2024-07-31 → 2027-07 | Ouvrir |
| NCT02760056 MST3K — Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A… |
Liothyronine sodium | SEP | Phase 1 | COMPLETED | En attente / non publié | Oregon Health and Science Univers… | United States · Oregon Health and Science University,… | 2016-06-06 → 2017-01-10 | Ouvrir |
| NCT04079088 Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Gl… |
BIIB061 | SEP | Phase 2 | WITHDRAWN | En attente / non publié | Biogen | Non communiqué | 2021-06-30 → 2024-09-18 | Ouvrir |
| NCT04377555 Prospective Study to Assess Disease Activity and Biomarkers in Minority… |
Ocrelizumab | SEP | Phase 4 | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States, Kenya, Puerto Rico · Atlanta Neuroscie… | 2020-07-30 → 2025-11-11 | Ouvrir |
| NCT04925557 Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progr… |
Mayzent | SEP | Phase 2/3 | TERMINATED | En attente / non publié | State University of New York at B… | United States · University at Buffalo, Buffalo Genera… | 2021-11-13 → 2023-08-05 | Ouvrir |
| NCT07779460 A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevu… |
A Study Comparing Effectiveness o… | SEP | À vérifier | RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States · Novartis, East Hanover, United States | 2026-04-08 → 2026-12-31 | Ouvrir |